RS2917677 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (19)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| heart rate (HR, mean, inv-normal transformed) | C | β: 0.045 | 1E-59 | PubMed |
| Type 2 diabetes | C | — | 6E-32 | PubMed |
| Body mass index | C | β: 0.022 | 5E-31 | PubMed |
| Cholesteryl Esters to Total Lipids in Medium VLDL percentage | T | β: 0.02 | 4E-24 | PubMed |
| Cholesteryl Esters to Total Lipids in Very Large VLDL percentage | T | β: 0.02 | 7E-22 | PubMed |
| Cholesterol to Total Lipids in Very Large VLDL percentage | T | β: 0.02 | 1E-21 | PubMed |
| Free Cholesterol to Total Lipids in Small VLDL percentage | T | β: 0.02 | 7E-21 | PubMed |
| Triglyceride levels | C | β: 0.019 | 3E-20 | PubMed |
| Triglycerides to Total Lipids in Small VLDL percentage | T | β: 0.02 | 1E-19 | PubMed |
| Cholesterol to Total Lipids in Small VLDL percentage | T | β: 0.02 | 3E-19 | PubMed |
| Triglycerides to Total Lipids in Very Large VLDL percentage | T | β: 0.02 | 2E-18 | PubMed |
| Cholesteryl Esters to Total Lipids in Large VLDL percentage | T | β: 0.02 | 3E-18 | PubMed |
| Free Cholesterol to Total Lipids in IDL percentage | T | β: 0.02 | 4E-17 | PubMed |
| Triglyceride levels in non-type 2 diabetes | — | — | 1E-16 | PubMed |
| Free Cholesterol to Total Lipids in Very Small VLDL percentage | T | β: 0.02 | 1E-15 | PubMed |
| Atherosclerosis (PheCode 440) | C | β: 0.069 | 9E-12 | PubMed |
| Medication use (HMG CoA reductase inhibitors) | T | β: 0.033 | 9E-9 | PubMed |
| Medication use (HMG CoA reductase inhibitors) | T | β: 0.03 | 1E-8 | PubMed |
| Childhood body mass index | C | β: 0.01 | 1E-6 | PubMed |